Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Replicative Cell Senescence02:15

Replicative Cell Senescence

3.9K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

3.5K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.5K
Introduction to Fibroblasts01:09

Introduction to Fibroblasts

3.3K
Rudolph Virchow discovered spindle-shaped cells called fibroblasts in 1858. Inactive fibroblasts, called fibrocytes, become activated by various stimuli, such as growth factors and inflammatory cytokines. Activated fibroblasts play a crucial role in wound healing, inflammation, formation of new blood vessels, and cancer progression. Uncontrolled activation of fibroblasts results in fibrosis, the excess deposition of fibrous tissue, which can lead to scarring and affect normal organs. This...
3.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomarkers of Pre-COPD Lung Function Trajectories in Middle Age: A Prospective Study From 1st to 6th Decade.

Respirology (Carlton, Vic.)·2026
Same author

Moving to better COPD care-changes to and challenges for GOLD.

American journal of respiratory and critical care medicine·2026
Same author

The Potential Role of DPP-1 Inhibitors in Chronic Obstructive Pulmonary Disease.

Archivos de bronconeumologia·2026
Same author

Clinical impact of mucus plugs in bronchiectasis.

Scientific reports·2026
Same author

How artificial intelligence could improve the diagnosis and management of COPD: a perspective from GOLD.

American journal of respiratory and critical care medicine·2026
Same author

Author Correction: The efficacy of chemotherapy is limited by intratumoral senescent cells expressing PD-L2.

Nature cancer·2026

Related Experiment Video

Updated: Oct 30, 2025

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

476

Cellular Senescence in Lung Fibrosis.

Fernanda Hernandez-Gonzalez1,2,3, Rosa Faner3, Mauricio Rojas4

  • 1Department of Pulmonology, ICR, Hospital Clinic, 08036 Barcelona, Spain.

International Journal of Molecular Sciences
|July 2, 2021
PubMed
Summary

Cellular senescence, a process where cells accumulate damage, drives age-related lung fibrosis. Targeting this senescence offers new therapeutic strategies for fibrosing interstitial lung diseases (ILDs).

Keywords:
agingpulmonary fibrosissenescencesenolyticssenomorphics

More Related Videos

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
13:59

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence

Published on: August 12, 2018

8.3K
Techniques to Induce and Quantify Cellular Senescence
06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

34.2K

Related Experiment Videos

Last Updated: Oct 30, 2025

Refined Murine Model of Idiopathic Pulmonary Fibrosis
07:51

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

476
A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
13:59

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence

Published on: August 12, 2018

8.3K
Techniques to Induce and Quantify Cellular Senescence
06:51

Techniques to Induce and Quantify Cellular Senescence

Published on: May 1, 2017

34.2K

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Aging Research

Background:

  • Fibrosing interstitial lung diseases (ILDs) are chronic, fatal lung conditions marked by irreversible scarring.
  • Age-related processes and cellular dysfunction contribute to susceptibility to lung fibrosis.
  • Cellular senescence, characterized by a pro-inflammatory secretome, is increasingly implicated in ILD pathobiology.

Purpose of the Study:

  • To review the role of cellular senescence in the initiation and progression of pulmonary fibrosis.
  • To highlight current and emerging therapeutic strategies targeting cellular senescence for fibrosing ILDs.

Main Methods:

  • Literature review of studies on cellular senescence and lung fibrosis.
  • Analysis of the molecular and cellular mechanisms linking senescence to fibrotic processes.
  • Examination of therapeutic approaches targeting senescent cells in ILDs.

Main Results:

  • Cellular senescence, a response to cellular damage, contributes to the pro-fibrotic environment in the lungs.
  • The senescence-associated secretome promotes molecular and cellular changes driving chronic fibrotic processes.
  • Targeting cellular senescence presents a promising avenue for novel ILD treatments.

Conclusions:

  • Cellular senescence is a key driver of lung fibrosis pathobiology.
  • Therapeutic strategies aimed at senescent cells hold potential for treating fibrosing ILDs.